Blogs - iGeneTech Bioscience Co., Ltd.

12

06, 2025

iGeneTech Supports Nature Research: Ancient DNA reveals a two-clanned matrilinealcommunityin Neolithic China

Was the organizational form of early human societies dominated by patrilineal or matrilineal systems? This question has sparked long-standing debates in academic circles. Previous whole-genome studies...



10

06, 2025

AIExome V5-Tumor Launched: Comprehensive Detection Meets Accurate Testing

In the field of tumor genetic testing, whole exome sequencing (WES) enables "panoramic" exploration, facilitating in-depth insight into tumor genetic profiles, accurately determining tumor t...



06

06, 2025

Capture All in Progress: Let Plant Exome Sequencing Boost Omics Research in Top Journals

Plant Whole Exome Sequencing: Focus on Precise Gene Sequencing in PlantsExons, as DNA regions directly involved in protein coding, carry the key genetic information of organisms. In plant research, Wh...



27

05, 2025

Literature Interpretation: Genetic Characteristics of Chinese Spinal Muscular Atrophy (SMA) Families and Whole Exome Sequencing

Spinal Muscular Atrophy (SMA)Spinal muscular atrophy (SMA) is a hereditary neuromuscular disorder categorized into 5q-SMA (caused by mutations in the SMN1 gene) and non-5q-SMA (resulting from mutation...



23

05, 2025

BisCap® Multi-Cancer Early Detection Panel: A Methylation-Based Multi-Cancer Early Detection and Screening Product

In March 2024, iGeneTech® officially launched its brand-new methylation-based multi-cancer early detection product, the BisCap® Multi-Cancer Early Detection Panel (MCED Panel), after multiple rounds...



14

05, 2025

Exploring Data Performance of iGeneTech® Multiple Products on the Element Biosciences AVITI™ Platform

Recently, iGeneTech conducted tests on the Element Biosciences AVITI™ sequencing platform for various types of liquid-phase probe capture panels. Data shows that multiple iGeneTech products demonstra...



08

05, 2025

Overview of the Origin and Current Situation of Minimal Residual Disease (MRD) in Solid Tumors

As an emerging technology in the field of tumor monitoring, the detection of Minimal Residual Disease (MRD) has increasingly become one of the important indicators for evaluating the effectiveness of ...



05

05, 2025

Transposase-based Capture Library Approach for Plant and Animal Sequencing

Tn5 transposase can bind insertion sequences in vitro, cut any double-stranded nucleic acid sequence, and then attach the insertion sequences bound by Tn5 to its ends. This characteristic of Tn5 has b...



30

04, 2025

Minimal Residual Disease (MRD) in Solid Tumors: Detection Strategy of Circulating Tumor DNA (ctDNA) MRD

There is currently a lack of a unified standard for how to choose the Minimal Residual Disease (MRD) detection strategy, and there are still some doubts about its clinical application. In this article...



28

04, 2025

iGeneTech takes the lead in initiating the era of free customization for MRD panels.

PART 01 The more monitoring sites, the higher the sensitivityDuring the MRD detection process, there are significant differences in the mutation profiles of patients with different cancer types. Simil...

